2022 - Research.com Best Female Scientist Award
Her primary areas of study are Cancer research, Hepatocellular carcinoma, Adenoma, Hepatocellular adenoma and Mutation. The various areas that Jessica Zucman-Rossi examines in her Cancer research study include Wnt signaling pathway, Carcinoma, CDKN2A and Gene mutation. Her Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Tumor suppressor gene, Hepatology, ARID1A and Somatic cell.
Her studies in Adenoma integrate themes in fields like Malignant transformation and Hepatocyte nuclear factors. As part of one scientific family, Jessica Zucman-Rossi deals mainly with the area of Hepatocellular adenoma, narrowing it down to issues related to the Germline mutation, and often Benign tumor. Her Mutation study results in a more complete grasp of Genetics.
Her primary areas of investigation include Cancer research, Hepatocellular carcinoma, Internal medicine, Pathology and Hepatocellular adenoma. The various areas that Jessica Zucman-Rossi examines in her Cancer research study include Carcinogenesis, Cancer, Tumor suppressor gene and Mutation, Gene mutation. Her Hepatocellular carcinoma study incorporates themes from Carcinoma, Gene, Bioinformatics and Hepatitis B virus.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. Her research in Pathology intersects with topics in Cirrhosis and Focal nodular hyperplasia. Her research integrates issues of Malignant transformation, HNF1A and Germline mutation in her study of Hepatocellular adenoma.
Her primary scientific interests are in Cancer research, Hepatocellular carcinoma, Internal medicine, Desk and Library science. Jessica Zucman-Rossi is studying HCCS, which is a component of Cancer research. Jessica Zucman-Rossi focuses mostly in the field of Hepatocellular carcinoma, narrowing it down to matters related to Hepatitis B and, in some cases, Viral hepatitis.
Jessica Zucman-Rossi has researched Internal medicine in several fields, including Gastroenterology and Oncology. Her Oncology research incorporates themes from Proportional hazards model and Retrospective cohort study. Her Carcinogenesis research integrates issues from Tumor microenvironment and Kinase.
Jessica Zucman-Rossi spends much of her time researching Cancer research, Hepatocellular carcinoma, Internal medicine, Oncology and Liver cancer. Jessica Zucman-Rossi studies Cancer research, namely HCCS. The concepts of her Hepatocellular carcinoma study are interwoven with issues in Hepatitis B, Virology, Carcinoma and Gene expression profiling.
Her research investigates the connection with Internal medicine and areas like Gastroenterology which intersect with concerns in Cohort and Hepatocellular adenoma. Her Oncology research incorporates elements of Tumor progression, Retrospective cohort study and Sorafenib. Jessica Zucman-Rossi has included themes like Chronic liver disease, Gene mutation, Small hairpin RNA and Telomerase reverse transcriptase in her Liver cancer study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Josep M Llovet;Robin Kate Kelley;Augusto Villanueva;Amit G Singal.
Nat Rev Dis Primers (2021)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
Cécile Guichard;Giuliana Amaddeo;Giuliana Amaddeo;Sandrine Imbeaud;Sandrine Imbeaud;Yannick Ladeiro;Yannick Ladeiro.
Nature Genetics (2012)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze;Sandrine Imbeaud;Eric Letouzé;Ludmil B. Alexandrov;Ludmil B. Alexandrov.
Nature Genetics (2015)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
Sandrine Boyault;Sandrine Boyault;David S. Rickman;Aurélien de Reyniès;Charles Balabaud.
MicroRNA Profiling in Hepatocellular Tumors Is Associated with Clinical Features and Oncogene/Tumor Suppressor Gene Mutations
Yannick Ladeiro;Yannick Ladeiro;Gabrielle Couchy;Gabrielle Couchy;Charles Balabaud;Paulette Bioulac-Sage.
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Jessica Zucman-Rossi;Emmanuelle Jeannot;Jeanne Tran Van Nhieu;Jean-Yves Scoazec.
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Jessica Zucman-Rossi;Augusto Villanueva;Jean-Charles Nault;Jean-Charles Nault;Josep M. Llovet;Josep M. Llovet;Josep M. Llovet.
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
Paulette Bioulac-Sage;Sandra Rebouissou;Sandra Rebouissou;Cristel Thomas;Cristel Thomas;Jean-Frédéric Blanc.
(Impact Factor: 9.917)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: